Remimazolam Besylate for Injection
HNMU-RAA-TS-2026-001
Approved small_molecule active
Quick answer
Remimazolam Besylate for Injection for Thoracic Surgery is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Thoracic Surgery
- Phase
- Approved
- Modality
- small_molecule
- Status
- active